Top compounds associated with response to CRYGD


Feature Type Standardized
Nominal ANOVA
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.099 0.004
mRNA foretinib CTRPv2 pan-cancer AAC -0.1 0.004
mRNA GSK429286A GDSC1000 pan-cancer AAC 0.092 0.005
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.13 0.006
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.097 0.006
mRNA masitinib GDSC1000 pan-cancer AAC 0.088 0.006
mRNA thapsigargin gCSI pan-cancer AAC -0.15 0.007
mRNA paclitaxel gCSI pan-cancer AAC -0.14 0.007
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.092 0.007
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.08 0.007
Download CSV